Baltimore-based blood test makes treatment plans clearer for cancer patients [CBS News]
Quest Diagnostics Incorporated (DGX)
Last quest diagnostics incorporated earnings: 4/22 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
ir.questdiagnostics.com
Company Research
Source: CBS News
HaystackMRD, made by Haystack Oncology within Quest Diagnostics, looks for signs of cancer that conventional methods may miss. While it's been in development for many, many years, the test was made clinically available for oncologists and pharmaceutical partners in late 2024. Finding the remaining cancer After going through treatments, even surgery, there's always the possibility that cancer can remain in the body. How much of the cancer is left can determine the next steps. An MRI, CT scan, and other imaging techniques have become the standard of care to figure this out, but the HaystackMRD is also helping answer the question. "The questions that persist for the patient are, 'Was the therapy I received working? Is it working if I'm currently on therapy?' said Dan Edelstein, Haystack Oncology's general manager. "'Did my cancer come back?'" The blood test looks for circulating tumor DNA (ctDNA) in the patient, which is a sign of cancer. Hillary Sloane, Haystack Oncolog
Show less
Read more
Impact Snapshot
Event Time:
DGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DGX alerts
High impacting Quest Diagnostics Incorporated news events
Weekly update
A roundup of the hottest topics
DGX
News
- 2 S&P 500 Stocks Worth Your Attention and 1 We Ignore [Yahoo! Finance]Yahoo! Finance
- City of Hope to Evaluate Quest Diagnostics' Haystack MRD® for Guiding Patient Management in Multiple Cancers [TheStreet.com]TheStreet.com
- City of Hope to Evaluate Quest Diagnostics' Haystack MRD® for Guiding Patient Management in Multiple CancersPR Newswire
- Quest Diagnostics (DGX) was given a new $210.00 price target by Evercore Inc.MarketBeat
- MyGevity Announces Nationwide Launch of Integrated Health Data Platform [Yahoo! Finance]Yahoo! Finance
DGX
Earnings
- 2/10/26 - Beat
DGX
Sec Filings
- 4/6/26 - Form DEFA14A
- 4/6/26 - Form DEF
- 4/2/26 - Form 4
- DGX's page on the SEC website